- Home
- MPTI vs ARCT Comparison
MPTI vs ARCT Comparison
Compare MPTI & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MPTI | ARCT |
|---|---|---|
| Founded | 1965 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 189.7M | 192.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | MPTI | ARCT |
|---|---|---|
| Price | $66.07 | $7.55 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 11 |
| Target Price | N/A | ★ $38.44 |
| AVG Volume (30 Days) | 32.3K | ★ 510.7K |
| Earning Date | 02-25-2026 | 03-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 19.64 | N/A |
| EPS | ★ 2.40 | N/A |
| Revenue | $52,989,000.00 | ★ $97,601,000.00 |
| Revenue This Year | $13.32 | N/A |
| Revenue Next Year | $10.56 | N/A |
| P/E Ratio | $26.77 | ★ N/A |
| Revenue Growth | ★ 12.79 | N/A |
| 52 Week Low | $34.50 | $5.85 |
| 52 Week High | $67.52 | $24.17 |
Technical Indicators
Market Signals| Indicator | MPTI | ARCT |
|---|---|---|
| Relative Strength Index (RSI) | 60.25 | 49.62 |
| Support Level | $61.50 | $7.00 |
| Resistance Level | $67.52 | $7.95 |
| Average True Range (ATR) | 2.70 | 0.37 |
| MACD | -0.31 | -0.02 |
| Stochastic Oscillator | 62.51 | 30.00 |
Price Performance
Historical ComparisonAbout MPTI M-tron Industries Inc.
M-Tron Industries Inc is a diversified holding company with subsidiaries engaged in designing, manufacturing, and marketing high-engineered, high-reliability frequency and spectrum control products used to control the frequency or timing of signals in electronic circuits in various applications. The company's serving markets are aerospace and defense, space, and avionics. The company offers products such as microwave and millimeter wave filters; cavity, crystal, ceramic, lumped element, and switched filters; crystal resonators, integrated microwave assemblies, and solid-state power amplifier products.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.